Kelly Standifer to Animals
This is a "connection" page, showing publications Kelly Standifer has written about Animals.
Connection Strength
0.570
-
Traumatic Brain Injury Induces Nociceptin/Orphanin FQ and Nociceptin Opioid Peptide Receptor Expression within 24 Hours. Int J Mol Sci. 2024 Jan 29; 25(3).
Score: 0.086
-
Exacerbated Headache-Related Pain in the Single Prolonged Stress Preclinical Model of Post-traumatic Stress Disorder. Cell Mol Neurobiol. 2021 Jul; 41(5):1009-1018.
Score: 0.068
-
Post-blast treatment with Nociceptin/Orphanin FQ peptide (NOP) receptor antagonist reduces brain injury-induced hypoxia and signaling proteins in vestibulomotor-related brain regions. Behav Brain Res. 2018 03 15; 340:183-194.
Score: 0.052
-
Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br J Pharmacol. 2015 Jan; 172(2):571-82.
Score: 0.044
-
Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Mol Pharmacol. 2013 May; 83(5):907-18.
Score: 0.040
-
Increased nociceptive sensitivity and nociceptin/orphanin FQ levels in a rat model of PTSD. Mol Pain. 2012 Oct 20; 8:76.
Score: 0.039
-
Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment. Neuropharmacology. 2012 Sep; 63(3):427-33.
Score: 0.038
-
Vesicle-associated membrane protein isoforms in the tiger salamander retina. J Comp Neurol. 2001 Mar 19; 431(4):424-36.
Score: 0.018
-
Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment. Methods Enzymol. 2000; 314:90-103.
Score: 0.016
-
G proteins and opioid receptor-mediated signalling. Cell Signal. 1997 May-Jun; 9(3-4):237-48.
Score: 0.014
-
Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol Pharmacol. 1996 Aug; 50(2):293-8.
Score: 0.013
-
Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression. J Neurochem. 1995 Nov; 65(5):1981-7.
Score: 0.012
-
Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol Sci. 1995 Oct; 16(10):344-50.
Score: 0.012
-
Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J Pharmacol Exp Ther. 1994 Sep; 270(3):1246-55.
Score: 0.011
-
Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron. 1994 Apr; 12(4):805-10.
Score: 0.011
-
Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations. J Pharmacol Exp Ther. 1993 Jul; 266(1):106-13.
Score: 0.010
-
Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone. Mol Pharmacol. 1991 Mar; 39(3):290-8.
Score: 0.009
-
Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb; 339(1-2):129-37.
Score: 0.008
-
Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina. BMC Neurosci. 2006 Jul 13; 7:54.
Score: 0.006
-
Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor. J Pharmacol Exp Ther. 2006 Jun; 317(3):1027-35.
Score: 0.006
-
Simultaneous alpha2B- and beta2-adrenoceptor activation sensitizes the alpha2B-adrenoceptor for agonist-induced down-regulation. J Pharmacol Exp Ther. 2004 Nov; 311(2):794-802.
Score: 0.006
-
Synaptic protein expression by regenerating adult photoreceptors. J Comp Neurol. 2002 Feb 11; 443(3):275-88.
Score: 0.005
-
Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats. Brain Res. 2000 Sep 08; 876(1-2):62-75.
Score: 0.004
-
GABA(A) receptor binding and localization in the tiger salamander retina. Vis Neurosci. 2000 Jan-Feb; 17(1):11-21.
Score: 0.004
-
3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line. J Pharmacol Exp Ther. 1997 Sep; 282(3):1291-7.
Score: 0.003
-
Sigma binding in a human neuroblastoma cell line. Neurochem Res. 1996 Nov; 21(11):1309-14.
Score: 0.003
-
Synthesis and characterization of substituted benzoylhydrazones of naloxone. Synapse. 1996 Oct; 24(2):193-201.
Score: 0.003
-
Characterizing kappa3 opioid receptors with a selective monoclonal antibody. Synapse. 1996 Mar; 22(3):247-52.
Score: 0.003
-
Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett. 1995 Sep 29; 198(2):99-102.
Score: 0.003
-
Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor. Mol Pharmacol. 1995 Jun; 47(6):1180-8.
Score: 0.003
-
TIPP[psi], a highly selective delta ligand. Neurosci Lett. 1994 Nov 07; 181(1-2):47-9.
Score: 0.003
-
Opioid binding in giant toad and goldfish brain. Receptor. 1994; 4(1):55-62.
Score: 0.003
-
Gender effects and central opioid analgesia. Pain. 1991 Apr; 45(1):87-94.
Score: 0.002
-
Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 1990 Dec 03; 535(1):101-9.
Score: 0.002
-
Modulation of mu 1, mu 2, and delta opioid binding by divalent cations. Biochem Pharmacol. 1990 Jul 15; 40(2):382-4.
Score: 0.002
-
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989 Nov; 251(2):477-83.
Score: 0.002
-
Irreversible binding and recovery of the norepinephrine uptake system using an alkylating derivative of norepinephrine. J Neurochem. 1988 Apr; 50(4):1044-52.
Score: 0.002
-
Carbostyril derivatives having potent beta-adrenergic agonist properties. J Med Chem. 1987 Sep; 30(9):1563-6.
Score: 0.002